Image 1
Glipizide Tablet
Product Images NDC 0591-0460
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 0591-0460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a medication package of Glipizide tablets with NDC number 0591-0460-01. The package contains 100 tablets manufactured by Reony and distributed by Teva. The usual dosage instruction is not available in the text. The medication should be stored below 30°C and kept out of reach of children. There is also a serialization coding area on the package.*
Image 3
This is a description of Glipizide tablets, a medication used to treat type 2 diabetes. It comes in a bottle of 100 tablets, with each tablet containing 10mg of Glipizide. It is important to keep this medication out of reach of children. The usual dosage should be determined by a healthcare professional and instructions for prescribing can be found inside. The medication should be stored below 30°C and is distributed by Teva Pharmaceuticals in the USA. The given code NOC 0592.0461.01 and the numbers 32075899-01 do not provide any significant information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
